Florida International University

FIU Digital Commons
Coronavirus Research at FIU
11-5-2021

Do post-COVID-19 symptoms exist? A longitudinal study of
COVID-19 sequelae in Wenzhou, China
Wenjie Sun
The Second affiliated hospital of Fujian traditional Chinese Medical University, Chin; Robert Stempel
college of public health and social work, Florida international University

Min Zhou
Department of infectious diseases, Xinyu people's Hospita

Jing Cai
Department of Comprehensive Medicine, Wenzhou Central Hospital Medical Group, Affiliated Dingli
Clinical Institute of Wenzhou Medical University

Jing Wu
Department of Infectious Diseases, Huashan hospital, Fudan university

Follow this and additional works at: https://digitalcommons.fiu.edu/covid-19_research

Recommended Citation
Sun, Wenjie; Zhou, Min; Cai, Jing; and Wu, Jing, "Do post-COVID-19 symptoms exist? A longitudinal study
of COVID-19 sequelae in Wenzhou, China" (2021). Coronavirus Research at FIU. 78.
https://digitalcommons.fiu.edu/covid-19_research/78

This work is brought to you for free and open access by FIU Digital Commons. It has been accepted for inclusion in
Coronavirus Research at FIU by an authorized administrator of FIU Digital Commons. For more information, please
contact dcc@fiu.edu.

Annales Médico-Psychologiques 179 (2021) 818–821

Available online at

ScienceDirect
www.sciencedirect.com

Original article

Do post-COVID-19 symptoms exist? A longitudinal study of COVID-19
sequelae in Wenzhou, China
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Objective. – We conducted a cohort of tracing discharge patients of COVID-19.
Materials and methods. – We used the Mann–Whitney U test, x2 test, or Fisher’s exact test to compare
differences between age groups and gender groups where appropriate.
Results. – Our study provides insights into the nature and severity of medical conditions speciﬁc to
survivors of COVID-19.
Conclusions. – It also highlights the potential mental health issues resulting from infectious disease
outbreaks within communities.
C 2021 The Authors. Published by Elsevier Masson SAS. This is an open access article under the CC BY-NCND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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R É S U M É
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Objectifs. – Nous avons suivi une cohorte de patients à la sortie du COVID-19.
Matériaux et méthodes. – Nous avons utilisé les test de Mann–Whitney U, de Fisher ou du Chi2 pour
comparer les différences entre les groupes d’âge et de genre, le cas échéant.
Résultats. – Notre étude fournit un aperçu de la nature et de la gravité des troubles médicaux propres
aux survivants du COVID-19.
Conclusions. – Elle met également en lumière les problèmes de santé mentale potentiels découlant des
éclosions de maladies infectieuses dans les collectivités.
C 2021 Les Auteurs. Publié par Elsevier Masson SAS. Cet article est publié en Open Access sous licence CC
BY-NC-ND (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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1. Abbreviations
COVID-19
PTSD
PCL-C
CT

 improvement in radiological abnormalities on chest computed
tomography (CT) or X-ray;
 and two consecutive negative detections of SARS-CoV-2 at least
24 h apart [10].

The novel Coronavirus
Post-traumatic stress disorder
PTSD checklist–civilian version
computed tomography

3.3. Statistical analysis

2. Introduction

Continuous and categorical variables were presented as median
(IQR) and n (%), respectively. We used the Mann–Whitney U test, x2
test, or Fisher’s exact test to compare differences between age
groups and gender groups where appropriate. The prevalence of
the total prevalence of symptom or sign was estimated with 95%
conﬁdence intervals. All tests were 2-sided, and a P value less than
0.05 was considered statistically signiﬁcant. All statistical analyses
were performed by the SPSS software, version 19.0 (IBM Corp,
Armonk, NY).

The novel Coronavirus (COVID-19) outbreak occurred in
Wuhan, China in December 2019 and spread to other countries.
Most patients’ symptoms have been mild to moderate and have
been resolved after receiving therapy.
The outbreak of COVID-19 in China has been deﬁned by the
World Health Organisation as a public health emergency of
international concern. The epidemic not only causes social panic,
but also causes physical and mental damage to people.
However, little is known about the patient’s health status or
disease prognosis when the COVID-19 patients are discharged from
hospitals. Moreover, recurrence of positive SARS-CoV-2 RNA has
been reported [1]. Of note, post-traumatic stress disorder (PTSD) had
been reported in other fatal virus infectious diseases [2,5,6]. Most
previous studies have focused on the effects of public health
emergencies on post-traumatic stress disorder in medical staff
(PTSD), but there are few studies on traumatic stress disorder in
patients. To the best of our knowledge, there are no studies reporting
on the status of discharged COVID-patients. Hence, we conducted a
prospective study on the COVID-19 patients from Wenzhou.

4. Results
Of 89 patients (median 43 years [IQR 31–52]), 43 were female
(Table 1). Of note, six patients (6.7%) had a recurrence of positive
RNA at the three-week follow-up. Several symptoms were
reported by the discharged patients, e.g. mild (e.g., fatigue) to
more severe complications requiring rehospitalisation or treatment. The most frequently reported symptoms were cough
(46.1%), fatigue (36.0%), expectoration properties (24.7%) (coughing up or spitting up material from the respiratory track), chest
tightness and insomnia (Table 1). Six patients (6.7%) had fever
(oral temperature higher than 37.48C). Three patients (3.4%)
complained of poor appetite, while two patients (2.2%) complained
of myalgia, arthralgia, oral ulcers and eye discomfort respectively.
Altogether, thirty-eight of the patients (42.7%) felt completely
improved, and forty-two patients (47.2%) felt much improved,
with one patient feeling no improvement and another patient
feeling even worse. There was no signiﬁcant difference in
symptoms, signs or RT-PCR conversion between the age and sex
groups (P > 0.05).
Only 73 patients were assessed for psychological stress by
administering the PTSD checklist–civilian version (PCL-C) (Table 2).
There were sixteen patients, more likely to be females aged over
45 years, who did not participate in the mental health assessment.
Eleven percent of the survivors had probable post-traumatic stress
disorder (PTSD) and 13.7% of the survivors, who manifested high
distress and with trauma exposure, had PTSD. Females had higher
scores of PTSD than males (P = 0.001), but there was no signiﬁcant
difference between age groups.

3. Methods
3.1. Patients
Until February 14, there were 139 conﬁrmed COVID-19 cases
admitted in Wenzhou sixth people’s hospital. Among them,
89 discharged patients were followed up during at least 3 weeks
with a semi-structured questionnaire address on post-COVID-19
symptoms and health status. The surveys collected information on
symptoms and diagnostic testing occurring any time during the
recovery period. Mental health status was also assessed by
administering the PTSD checklist–civilian version (PCL-C)
[9]. The ethics commissions of Wenzhou central hospital medical
group hospital approved the study.
The participants responded to the PLC-C, which includes
17 items on a 5-point scale, ranging from 1 (not at all) to 5
(extremely) in three areas: Intrusion, avoidance and numbing, and
hyperarousal. A PTSD severity score was computed by summing up
all symptom scores. Respondents indicated the extent to which
they have been affected by symptoms over the past month. The
PCL-C total score ranges from 17 to 85, with higher scores
indicating greater PTSD symptom severity. It was recommended
that, when the instrument was used as a continuous measure, a
cut-off score of 50 is optimal for making the diagnosis of combat
related PTSD. The scores that range from 38–49 suggest probable
PTSD.
The protocol was approved by the review board at the Wenzhou
central hospital. Written informed consent was obtained from all
participants.

5. Discussion
Post-COVID-19 symptoms include, but are not restricted to,
musculoskeletal pain, headache, and ocular problems. Our results
are consistent with previous studies of similar infectious diseases,
such as Ebola, SARS, and MERS that result in emergency conditions
[4,7,8]. Most symptoms reported in the present study are not
speciﬁc, which could be due to previous chronic disease conditions
patients already suffer from, or it could be temporary symptoms
related to COVID-19. It might resolve in the future. However, longterm follow-up is needed.
Recurrence of positive SARS-CoV-2 RNA is a unique phenomenon. It is different from coronaviruses, such as SARS and MERS,
which do not similarly reported relapses in the literature resulting
among discharged patients. In the present study, there were 6 cases
among 89 discharge patients (6.7% with 95% CI [1.4–12.1]). The
mechanism is still unclear until now. The potential explanation is

3.2. Discharge criteria
According to the national criteria, the discharge criteria were:
 afebrility for at least 3 days;
 obvious alleviation of respiratory symptoms;
819

M. Zhou, J. Cai, W. Sun et al.

Annales Médico-Psychologiques 179 (2021) 818–821

Table 1
Selected signs and symptoms reported by COVID-19 patients 3 weeks after discharge.
Symptoms or signs

Total (n = 89)
No. (% [95% CI])

Fever
Cough
Expectoration
Fatigue
Diarrhea
Chest tightness
Poor appetite
Insomnia
Recurrence of positive SARS-CoV-2 RNA
General recovery
Complete improvement
Much improvement
Slight improvement
No improvement
Worse

Age, No. (%)

Gender, No. (%)

< 45y
(n = 47)

 45y
(n = 42)

P value

Female
(n = 43)

Male
(n = 46)

P value

6 (6.7 [1.4–12.1])
41 (46.1 [35.5–56.6])
22 (24.7 [15.6–33.9])
32 (36.0 [25.8–46.1])
16 (18.0 [9.8–26.1])
22 (24.7 [15.6–33.9])
3 (3.4 [0–7.2])
22 (24.7 [15.6–33.9])
6 (6.7 [1.4–12.1])

3 (6.4)
20 (42.6)
9 (19.1)
14 (29.8)
9 (19.1)
10 (21.3)
0 (0.0)
9 (19.1)
4 (8.5)

3 (7.1)
21 (50)
13 (31.0)
18 (42.9)
7 (16.7)
12 (28.6)
3 (7.1)
13 (31.0)
2 (4.8)

1.000
0.528
0.418
0.269
0.790
0.468
0.101
0.226
0.680
1.000

4 (9.3)
20 (46.5)
11 (25.6)
18 (41.9)
7 (16.3)
13 (30.2)
4 (9.3)
13 (30.2)
3 (7.0)

2 (4.3)
21 (45.7)
11 (23.9)
14 (30.4)
9 (19.6)
9 (19.6)
0 (0.0)
9 (19.6)
3 (6.5)

0.424
1.000
0.706
0.279
0.786
0.634
0.051
0.326
1.000
1.000

38 (42.7 [32.2–53.2])
42 (47.2 [36.6–57.8])
7 (7.9 [2.2–13.6])
1 (1.1 [0–3.4])
1 (1.1 [0–3.4])

25 (53.2)
21 (44.7)
1 (2.1)
0 (0.0)
0 (0.0)

13 (31.0)
21 (50)
6 (14.3)
1 (2.4)
1 (2.4)

19 (44.2)
16 (37.2)
6 (14.0)
1 (2.3)
1 (2.3)

19 (41.3)
26 (56.5)
1 (2.2)
0 (0.0)
0 (0.0)

Table 2
PTSD checklist–civilian version (PCL-C) by COVID-19 patients after discharge.
Total (n = 73)
No. (% [95% CI])

Median (IQR)
Normal score = 037
Probable PTSD score = 3849
PTSD score  50

28.0 (20.0–40.0)
55 (75.3 [65.2–85.5])
8 (11.0 [3.6–18.3])
10 (13.7 [5.6–21.8])

Age, No. (%)

Gender, No. (%)

< 45y
(n = 42)

 45y
(n = 31)

P value

Female
(n = 33)

Male
(n = 40)

P value

27.5 (18.8–44.3)
30 (71.4)
4 (9.5)
8 (19.0)

28.0 (22.0–37.0)
25 (80.6)
4 (12.9)
2 (6.4)

0.942
1.000

31.0 (27.5–43.0)
22 (66.7)
5 (15.2)
6 (18.2)

23.0 (17.0–34.0)
33 (82.5)
3 (7.5)
4 (10.0)

0.001
1.000

7. Implications

that health systems are being overwhelmed and are not able to
adequately follow up with patient’s post-discharge. The hospitals
are often forced to discharge these patients, even if they haven’t
fully recovered, as the need for beds is immense. Future studies on
the clinical symptoms of those patients and pathology are warrant.
COVID-19 pandemic has been associated with increases in
mental health issues among COVID-19 patients. Typically, PTSD is
triggered by a terrifying or traumatic event, which could result
from either experiencing it or witnessing it. As for COVID-19, the
emergency environmental conditions that have been induced with
this infectious disease might produce unique characteristics that
are resulting in PTSD among COVID-19 survivors. Of note, most
COVID-19 patients are more likely to be infected by close contact
from family members, for example. As a result, those patients
might be experiencing the impacts of both COVID-19 exposure in
themselves as well as witnessing it in their family member. This
could result in a double exposure effect and could have a more
severe impact. Also, our results conﬁrm that gender difference
exists in PTSD [3]. It could be due to the hormone and neurosteroid/
peptide differences from both pre-clinical and clinical research [3].

Our study provides insights into the nature and severity of
medical conditions speciﬁc to survivors of COVID-19. It also
highlights the potential mental health issues resulting from
infectious disease outbreaks within communities. The long-term
consequences may not just be physical symptoms, which could
necessitate comprehensive and coordinated mental health responses. Lastly, this study has underscored the importance of better
understanding the conditions that lead to reinfection and what this
means for measures that are undertaken to decrease disease
transmission.

8. Conclusion
Long-term psychological support could be a crucial element
aiding in reducing mortality and morbidity, and promoting overall
effectiveness of efforts to halt COVID-19 transmission. This study
provides a reference for improving people’s mental health and
psychological adaptability during any future COVID-19-like
pandemic.

6. Limitations

Funding

Our study has several limitations. Dysfunctional information
related to complained symptoms was not accessed. Most symptoms
were self-reported and were not crosschecked against medical
charts. Also, follow-up time since hospital discharge was short, and
PTSD symptoms can manifest years after the traumatic situation
has occurred. The pathogenesis of the symptoms reported by
survivors of COVID-19 is unclear and requires further study.
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